Saamya Biotech (India) Limited reported unaudited standalone earnings results for first quarter ended June 30, 2015. For the quarter, the company reported total income from operation of INR 67,314,705. Loss from operations before other income, finance cost and exceptional items of INR 2,391,654 compared to INR 902,287 a year ago.

Loss from ordinary activities before tax was INR 2,408,200 compared to INR 959,306 a year ago. Net loss for the period was INR 2,408,200 or INR 0.10 per basic and diluted share compared to INR 959,306 or INR 0.04 per basic and diluted share for the same period a year ago.